THE TREATMENT OF  METASTATIC PROSTATIC CANCER WITH DITHIZONE (DIPHENYLTHIOCARBAZONE).
D000135:Acid Phosphatase / Q000097:blood*; D000469:Alkaline Phosphatase / Q000097:blood*; D002277:Carcinoma; D002369:Castration; D004230:Dithizone; D004967:Estrogens; D006801:Humans; D007202:Indicators and Reagents; D008297:Male; D009369:Neoplasms / Q000532:radiotherapy*; D009919:Orchiectomy; D010179:Pancreas; D011467:Prostate; D011470:Prostatic Hyperplasia; D011471:Prostatic Neoplasms; D012106:Research; D012160:Retina; D012661:Semen; D013094:Spermatozoa; D013739:Testosterone; D014116:Toxicology; D014555:Urination Disorders; D015032:Zinc
D004967:Estrogens; D007202:Indicators and Reagents; D013739:Testosterone; D004230:Dithizone; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D015032:Zinc
BLOOD ACID PHOSPHATASE; BLOOD ALKALINE PHOSPHATASE; CARCINOMA; CASTRATION; ESTROGENS; EXPERIMENTAL LAB STUDY; INDICATORS AND REAGENTS; NEOPLASM RADIOTHERAPY; PANCREAS; PROSTATE; PROSTATIC HYPERTROPHY; PROSTATIC NEOPLASMS; RETINA; SEMEN; SPERMATOZOA; TESTOSTERONE; TOXICOLOGIC REPORT; URINATION DISORDERS; ZINC